Eric Topol, MD

Founder and Director, Scripps Research Translational Institute
Executive Vice President, Scripps Research
Professor, Molecular Medicine, Scripps Research
Gary and Mary West Endowed Chair of Innovative Medicine, Scripps Research


Eric Topol, a professor in the Department of Molecular Medicine, is an executive vice president at Scripps Research and the founder and director of Scripps Research Translational Institute (previously Scripps Translational Science Institute). His work melds genomics, big data, and both information technologies and digital health technologies to advance the promise of personalized medicine.

In 2016, the National Institutes of Health awarded Topol a $207 million grant to lead a significant part of the All of Us Research Program, a long-term research endeavor aimed at understanding how a person’s genetics, environment and lifestyle can guide approaches to preventing or treating disease.

Topol has published over 1,100 peer-reviewed articles, and his more than 200,000 citations place him among the top 10 most cited researchers in medicine as measured by Thomson Reuters’ Institute for Scientific Information. Widely viewed as one of the most influential physician leaders in the country, Topol is the author of two bestselling books on the future of medicine: The Creative Destruction of Medicine and The Patient Will See You Now. His next book, Deep Medicine, focused on artificial intelligence, will be published in 2019.

Topol earned his medical degree from the University of Rochester and, after additional training at the University of California, San Francisco and Johns Hopkins University, went to the University of Michigan where he became a tenured professor. Subsequently, as chief of cardiovascular medicine at Cleveland Clinic, he founded a new medical school and led the organization to become the #1 center for heart care in the nation. He was elected to the National Academy of Medicine in 2004. Three years later, he founded the Scripps Translational Science Institute, which joined Scripps Research in 2017.


View all people